IHC analysis was used to examine expression levels of LSD1 and the methylation status of H3K4 in commercial tissue microarrays (TMA) containing 203 tissue samples from different stages of bladder cancer and 13 normal bladder tissue controls (Biomatrix, LLC, Plantation, FL, USA). The gene discussed is KDM1A; the disease is urinary bladder cancer.